๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Platelet function in pregnant women receiving aspirin and dipyridamole

โœ Scribed by Keiko Kinouchi; Tomio Fujita; Chie Narahara; Seiji Kitamura

Publisher
Springer
Year
2000
Tongue
English
Weight
59 KB
Volume
14
Category
Article
ISSN
0913-8668

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Trial of platelet-inhibiting drug in scl
Trial of platelet-inhibiting drug in scleroderma double-blind study with dipyridamole and aspirin
โœ Victoria L. Beckett; Doyt L. Conn; Valentin Fuster; Philip J. Osmundson; Cameron ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 629 KB

In a randomized, double-blind, controlled study, 28 patients with early scleroderma received dipyridamole (225 mg/day) and aspirin (975 mg/day) or placebo for 1-2 years. No significant clinical or objective laboratory improvement was noted in either group. Platelet survival time, plasma renin activi

Effects of aspirin, dipyridamole, nifedi
Effects of aspirin, dipyridamole, nifedipine and cavinton which act on platelet aggregation induced by different aggregating agents alone and in combination
โœ S. E. Akopov; E. S. Gabrielian ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 253 KB

The effects of aspirin, nifedipine, dipyridamole and cavinton on platelet aggregability in patients with atherosclerosis has been studied using various agents to induce aggregation. The drugs reduced platelet aggregability when aggregation was induced by ADP, adrenaline, or collagen alone. However,

Prospective evaluation of bone density i
Prospective evaluation of bone density in pregnant women receiving the low molecular weight heparin enoxaparin sodium
โœ Holly L. Casele; Steven A. Laifer ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 113 KB ๐Ÿ‘ 2 views

Objective: To evaluate changes in bone density in women receiving enoxaparin sodium during pregnancy. Methods: Bone density in the proximal femur was serially measured in 16 women receiving enoxaparin sodium (40 mg daily) during pregnancy. Baseline measurements were taken within 2 weeks of starting